Streetbeat News

Regulatory

CAE

Levi & Korsinsky has initiated an investigation into CAE Inc. for potential violations of federal securities laws, which may have impacted investors who purchased CAE shares on the NYSE.

Portfolio Pulse from

November 11, 2024 | 12:45 pm

AAAU

Gold prices are approaching a critical support level at $2,646, with upcoming inflation data and Federal Reserve remarks potentially influencing a bearish trend if this level is breached.

Portfolio Pulse from

November 11, 2024 | 12:45 pm

NVAX

Levi & Korsinsky has initiated an investigation into Novavax, Inc. (NVAX) for potential securities fraud. This follows the FDA's clinical hold on Novavax's combination influenza and Covid-19 shot and its stand-alone influenza vaccine.

Portfolio Pulse from

November 11, 2024 | 12:45 pm

ACHFF

Arch Biopartners Inc. has started dosing the first patient in Canada for its Phase II trial of LSALT peptide, aimed at preventing and treating cardiac surgery-associated acute kidney injury.

Portfolio Pulse from

November 11, 2024 | 12:45 pm

AZN

Levi & Korsinsky has initiated an investigation into AstraZeneca PLC for potential violations of federal securities laws. This follows a report by Yicai about a fraud investigation involving AstraZeneca and several Chinese government agencies, implicating senior executives.

Portfolio Pulse from

November 11, 2024 | 12:45 pm

AAAU

Gold prices are approaching a critical support level at $2,646, with upcoming inflation data and Federal Reserve remarks potentially influencing a bearish trend if this level is breached.

Portfolio Pulse from

November 11, 2024 | 12:45 pm

SUI

Levi & Korsinsky has initiated an investigation into Sun Communities, Inc. (NYSE:SUI) for potential violations of federal securities laws, following a report by Blue Orca Capital.

Portfolio Pulse from

November 11, 2024 | 12:45 pm

HUMA

Levi & Korsinsky has initiated an investigation into Humacyte, Inc. for potential violations of federal securities laws following FDA findings of significant quality control issues at its North Carolina facility.

Portfolio Pulse from

November 11, 2024 | 12:45 pm

PAC

Levi & Korsinsky has initiated an investigation into PACS Group, Inc. (NYSE:PAC) for potential violations of federal securities laws following a report by Hindenburg Research. The report, released on November 4, 2024, was the result of a 5-month investigation into PACS' claimed 'turnaround'.

Portfolio Pulse from

November 11, 2024 | 12:45 pm

ARGX

ZLAB

Zai Lab Limited and argenx have received approval from China's NMPA for VYVGART Hytrulo, a treatment for chronic inflammatory demyelinating polyneuropathy (CIDP).

Portfolio Pulse from

November 11, 2024 | 12:45 pm